Sweden · Delayed Price · Currency is SEK CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of SEK 3.34 billion. The enterprise value is 3.22 billion.
| Market Cap | 3.34B |
| Enterprise Value | 3.22B |
Important Dates
The last earnings date was Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
CellaVision AB has 23.85 million shares outstanding.
| Current Share Class | 23.85M |
| Shares Outstanding | 23.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 62.36% |
| Float | 19.50M |
Valuation Ratios
The trailing PE ratio is 25.87 and the forward PE ratio is 21.07. CellaVision AB's PEG ratio is 1.83.
| PE Ratio | 25.87 |
| Forward PE | 21.07 |
| PS Ratio | 4.52 |
| PB Ratio | 3.77 |
| P/TBV Ratio | 4.89 |
| P/FCF Ratio | 21.70 |
| P/OCF Ratio | 19.35 |
| PEG Ratio | 1.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.59, with an EV/FCF ratio of 20.92.
| EV / Earnings | 24.94 |
| EV / Sales | 4.36 |
| EV / EBITDA | 19.59 |
| EV / EBIT | 19.59 |
| EV / FCF | 20.92 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.31 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.34 |
| Interest Coverage | 372.65 |
Financial Efficiency
Return on equity (ROE) is 15.11% and return on invested capital (ROIC) is 17.64%.
| Return on Equity (ROE) | 15.11% |
| Return on Assets (ROA) | 9.38% |
| Return on Invested Capital (ROIC) | 17.64% |
| Return on Capital Employed (ROCE) | 16.27% |
| Weighted Average Cost of Capital (WACC) | 9.40% |
| Revenue Per Employee | 2.94M |
| Profits Per Employee | 514,299 |
| Employee Count | 241 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, CellaVision AB has paid 34.24 million in taxes.
| Income Tax | 34.24M |
| Effective Tax Rate | 20.97% |
Stock Price Statistics
The stock price has decreased by -21.26% in the last 52 weeks. The beta is 0.96, so CellaVision AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -21.26% |
| 50-Day Moving Average | 133.12 |
| 200-Day Moving Average | 149.94 |
| Relative Strength Index (RSI) | 51.99 |
| Average Volume (20 Days) | 25,478 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of SEK 739.15 million and earned 129.09 million in profits. Earnings per share was 5.41.
| Revenue | 739.15M |
| Gross Profit | 507.87M |
| Operating Income | 164.34M |
| Pretax Income | 163.33M |
| Net Income | 129.09M |
| EBITDA | 164.34M |
| EBIT | 164.34M |
| Earnings Per Share (EPS) | 5.41 |
Balance Sheet
The company has 172.19 million in cash and 52.27 million in debt, with a net cash position of 119.92 million or 5.03 per share.
| Cash & Cash Equivalents | 172.19M |
| Total Debt | 52.27M |
| Net Cash | 119.92M |
| Net Cash Per Share | 5.03 |
| Equity (Book Value) | 885.90M |
| Book Value Per Share | 37.14 |
| Working Capital | 305.12M |
Cash Flow
In the last 12 months, operating cash flow was 172.59 million and capital expenditures -18.73 million, giving a free cash flow of 153.86 million.
| Operating Cash Flow | 172.59M |
| Capital Expenditures | -18.73M |
| Depreciation & Amortization | 21.71M |
| Net Borrowing | -15.63M |
| Free Cash Flow | 153.86M |
| FCF Per Share | 6.45 |
Margins
Gross margin is 68.71%, with operating and profit margins of 22.23% and 17.46%.
| Gross Margin | 68.71% |
| Operating Margin | 22.23% |
| Pretax Margin | 22.10% |
| Profit Margin | 17.46% |
| EBITDA Margin | 22.23% |
| EBIT Margin | 22.23% |
| FCF Margin | 20.82% |
Dividends & Yields
This stock pays an annual dividend of 2.75, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | 2.75 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 50.81% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.96% |
| Earnings Yield | 3.87% |
| FCF Yield | 4.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for CellaVision AB is 176.75, which is 26.25% higher than the current price. The consensus rating is "Buy".
| Price Target | 176.75 |
| Price Target Difference | 26.25% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 7.73% |
| EPS Growth Forecast (3Y) | 10.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |